|
PPP2R1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.70690000414575E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97090122000532E-11 |
| Normal-vs-Stage2 |
1.82829999999523E-05 |
| Normal-vs-Stage3 |
3.78080000640324E-09 |
| Normal-vs-Stage4 |
2.69050004497728E-09 |
| Stage1-vs-Stage2 |
7.456400E-01 |
| Stage1-vs-Stage3 |
9.903900E-02 |
| Stage1-vs-Stage4 |
1.598110E-02 |
| Stage2-vs-Stage3 |
1.158800E-01 |
| Stage2-vs-Stage4 |
5.000000E-02 |
| Stage3-vs-Stage4 |
4.436800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72309999602049E-08 |
| Normal-vs-AfricanAmerican |
4.71999994644534E-09 |
| Normal-vs-Asian |
4.320000E-03 |
| Caucasian-vs-AfricanAmerican |
3.511600E-01 |
| Caucasian-vs-Asian |
9.190200E-01 |
| AfricanAmerican-vs-Asian |
6.884000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87700005433089E-09 |
| Normal-vs-Female |
3.70419999999871E-05 |
| Male-vs-Female |
5.785100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.44599999973849E-07 |
| Normal-vs-Extreme_Weight |
2.11541895112077E-12 |
| Normal-vs-Obese |
4.48589999590965E-08 |
| Normal-vs-Extreme_Obese |
9.45150000042361E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.933770E-01 |
| Normal_Weight-vs-Obese |
8.999000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.059400E-01 |
| Extreme_Weight-vs-Obese |
1.139570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.029000E-01 |
| Obese-vs-Extreme_Obese |
6.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.846480E-04 |
| Normal-vs-Age(41-60Yrs) |
8.4099005537297E-10 |
| Normal-vs-Age(61-80Yrs) |
2.69819999676457E-09 |
| Normal-vs-Age(81-100Yrs) |
6.32499999999592E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.870800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.801700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.652200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.044700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.995000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.648800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.75170003344516E-09 |
| Normal-VS-Type2 PRCC |
2.96689994794264E-09 |
| Normal-VS-KIRP CIMP |
6.497700E-03 |
| Normal-VS-Unclassified PRCC |
5.21479999959773E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.073850E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.323700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.632600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.137000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.636800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.268200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74780001582775E-09 |
| Normal-vs-N1 |
1.03330000111868E-08 |
| Normal-vs-N2 |
8.502400E-03 |
| N0-vs-N1 |
8.247600E-01 |
| N0-vs-N2 |
9.520400E-01 |
| N1-vs-N2 |
9.613200E-01 |
|
|
